Towards Healthcare
Human Microbiome Market to Rise at 30.97% CAGR till 2035

Human Microbiome Market Fueled by Modern Healthcare Needs

Market insights predict the global human microbiome industry will increase from USD 1.23 billion in 2025 to USD 18.27 billion by 2035, achieving a CAGR of 30.97%. The market is growing due to rising research on the role of gut health in chronic diseases and increasing demand for microbiome-based therapeutics. Additionally, advancements in sequencing technologies and personalized medicine are driving market expansion. North America is leading due to the rising focus on gut health among Americans. 

Content

  • Last Updated: 27 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The human microbiome market in 2026 is valued at USD 1.61 billion and is projected to climb to USD 18.27 billion by 2035, with a CAGR of 30.97% over the forecast period.

North America is currently leading the human microbiome market due to widespread use of advanced imaging technologies and a mature healthcare system.

Some key players include Finch Therapeutics, Vedanta Biosciences, Ferring Pharmaceuticals, MaaT Pharma, BiomX Inc., 4D pharma plc, and Synlogic.

It plays a key role in digestion, immunity, metabolism, and even mental health by interacting with the body systems and influencing biological processes.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions